MedPath

GLENMARK PHARMACEUTICALS LIMITED

🇮🇳India
Ownership
-
Employees
-
Market Cap
-
Website

To Evaluate Safety, Tolerability and Pharmacokinetics of GRC 27864 in Healthy Subjects and Elderly Healthy Subjects

Phase 1
Completed
Conditions
Healthy
Interventions
Drug: Placebo
First Posted Date
2015-02-11
Last Posted Date
2015-12-15
Lead Sponsor
Glenmark Pharmaceuticals S.A.
Target Recruit Count
32
Registration Number
NCT02361034
Locations
🇬🇧

Covance Clinical Research Unit Ltd, Leeds, Yorkshire, United Kingdom

© Copyright 2025. All Rights Reserved by MedPath